Descriptor English: | Tigecycline | ||||||
Descriptor Spanish: |
Tigeciclina
| ||||||
Descriptor Portuguese: | Tigeciclina | ||||||
Descriptor French: | Tigecycline | ||||||
Entry term(s): |
9-(tert-Butylglycylamido)minocycline GAR 936 GAR-936 GAR936 TBG-MINO Tygacil |
||||||
Tree number(s): |
D02.455.426.559.847.562.900.937 D04.615.562.900.937 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000078304 | ||||||
Scope note: | A tetracycline derivative that acts as a protein synthesis inhibitor. It is used as an antibacterial agent for the systemic treatment of complicated skin and intra-abdominal infections. It is also used for the treatment of community-acquired pneumonia. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Bacterial Agents Protein Synthesis Inhibitors |
||||||
Registry Number: | 70JE2N95KR | ||||||
CAS Type 1 Name: | 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- | ||||||
Public MeSH Note: | 2019; TIGECYCLINE was indexed under MINOCYCLINE/analogs & derivatives 1999-2018 |
||||||
History Note: | 2019 (1999) |
||||||
DeCS ID: | 57796 | ||||||
Unique ID: | D000078304 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/06/19 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Tigecycline
- Preferred
Tygacil
- Narrower
GAR 936
- Narrower
Concept UI |
M0305009 |
Scope note | A tetracycline derivative that acts as a protein synthesis inhibitor. It is used as an antibacterial agent for the systemic treatment of complicated skin and intra-abdominal infections. It is also used for the treatment of community-acquired pneumonia. |
Preferred term | Tigecycline |
Entry term(s) |
9-(tert-Butylglycylamido)minocycline TBG-MINO |
Concept UI |
M0489861 |
Preferred term | Tygacil |
Concept UI |
M0490506 |
Preferred term | GAR 936 |
Entry term(s) |
GAR-936 GAR936 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey